Psoriasis

Código QR

Psoriasis

Guardado en:

Detalles Bibliográficos
Autor principal:	MOLL LEE,NORMAN
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Chilena de Pediatría 1947
Materias:	Psoriasis
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0370-41061947000400003
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Psoriasis eritrodérmica y psoriasis artropática: Relate de dos casos
por: STEEGER,ADALBERTO, et al.
Publicado: (1956)

Psoriasis Pustular
por: ROSSELOT,JORGE
Publicado: (1951)

Management of scalp psoriasis: current perspectives
por: Blakely K, et al.
Publicado: (2016)

Clusterin and Psoriasis; What is the Relation?
por: Osama Hashem, et al.
Publicado: (2020)

Diagnosis and screening of patients with generalized pustular psoriasis
por: Ly K, et al.
Publicado: (2019)

Estudio de enfermedad celíaca en pacientes con psoriasis
por: Calderón H,Perla, et al.
Publicado: (2007)

Risankizumab for Plaque and Guttate Psoriasis in a Patient With IgA-Related Glomerulonephritis
por: Annunziata Dattola, et al.
Publicado: (2021)

Psoriasis and alcohol
por: Svanström C, et al.
Publicado: (2019)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo Y, et al.
Publicado: (2021)

The new external drug for the treatment of psoriasis based on inhibition of serine proteases
por: Alexander S. Zhukov, et al.
Publicado: (2021)

Pustular psoriasis: pathophysiology and current treatment perspectives
por: Benjegerdes KE, et al.
Publicado: (2016)

An Atypical Case of Pustular Psoriasis Presenting With Severe Subungual Abscesses Involving All Fingers
por: A. Tulin Mansur
Publicado: (2019)

Effectiveness of Short-Term Physical Agents Treatment on Macroscopic Morphology in Patients with Plaque Psoriasis
por: Norambuena-Mardones,Leandra, et al.
Publicado: (2019)

THE INFLUENCE OF PATHOLOGICAL PROCESS DURATION ON PEROXIDE BLOOD STATUS OF PSORIASIS PATIENTS
por: E. V. Falko, et al.
Publicado: (2012)

Psoriasis and uveitis: links and risks
por: Fotiadou C, et al.
Publicado: (2019)

Psoriasis: Targets and Therapy
Publicado: (2012)

Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
por: Budamakuntla L, et al.
Publicado: (2019)

The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
por: Georgios Kokolakis, et al.
Publicado: (2021)

Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy
por: Agozzino M, et al.
Publicado: (2017)

Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients
por: Anani HAA, et al.
Publicado: (2020)

Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Aimilios Lallas, et al.
Publicado: (2016)

Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease
por: Wang,Wuyuntana, et al.
Publicado: (2019)

Current knowledge on psoriasis and autoimmune diseases
por: Ayala-Fontánez N, et al.
Publicado: (2016)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh RK, et al.
Publicado: (2016)

Eficacia y seguimiento en el largo plazo de pacientes con psoriasis vulgar moderada a severa en tratamiento con infliximab (Remicade®)
por: Valdés A,María del Pilar, et al.
Publicado: (2006)

Estimation of physiotherapy effectiveness in complex treatment of psoriasis
por: Y. A. Zgura, et al.
Publicado: (2014)

Remisión de la psoriasis luego de bypass gástrico
por: Farías N,María Magdalena, et al.
Publicado: (2012)

Automatic Image Characterization of Psoriasis Lesions
por: Javier Martínez-Torres, et al.
Publicado: (2021)

Therapeutic drug monitoring of biologics in psoriasis
por: Liau MM, et al.
Publicado: (2019)

Phosphodiesterase-4 Inhibition in Psoriasis
por: Milakovic M, et al.
Publicado: (2021)

Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
por: Teklu M, et al.
Publicado: (2021)

Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic
por: Haulrig MB, et al.
Publicado: (2021)

Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
por: Machado Á, et al.
Publicado: (2018)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: S. V. Smirnova, et al.
Publicado: (2014)

THE GROUNDS OF CLARITROMYCIN USE IN THE TREATMENT OF PSORIASIS
por: V. L. Rybkina
Publicado: (2014)

Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis
por: Paolo Gisondi, et al.
Publicado: (2021)

Serum TSLP is a potential biomarker of psoriasis vulgaris activity
por: El-Ghareeb MI, et al.
Publicado: (2019)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
por: Hanley T, et al.
Publicado: (2016)

Cognitive Process of Psoriasis and Its Comorbidities: From Epidemiology to Genetics
por: Jing Gao, et al.
Publicado: (2021)

Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
por: Betul Tas, et al.
Publicado: (2021)